Skip to main content

Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

Clinical Info HIV.gov logo
In affiliation with HIV.gov

Main navigation

  • Home
  • Guidelines
  • Drug Database
  • Glossary
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Guidelines
  3. Pediatric ARV
  4. Overview
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Guidelines search

  • Adult and Adolescent ARV (19)
  • Adult and Adolescent Opportunistic Infection (33)
  • Caring for Persons with HIV in Disaster Areas (4)
  • COVID-19 and Persons with HIV (Interim Guidance) (1)
  • Pediatric ARV (17)
  • Pediatric Opportunistic Infection (31)
  • Perinatal (16)
Version:
Brief Full
What's New in the Guidelines Guidelines Panel Members Financial Disclosure Introduction Maternal HIV Testing and Identification of Perinatal HIV Exposure Diagnosis of HIV Infection in Infants and Children Clinical and Laboratory Monitoring of Pediatric HIV Infection When to Initiate Therapy in Antiretroviral-Naive Children
Regimens Recommended for Initial Therapy of Antiretroviral-Naive Children
What Not to Start: Regimens Not Recommended for Initial Therapy of Antiretroviral-Naive Children
Antiretroviral Management of Newborns with Perinatal HIV Exposure or HIV Infection Specific Considerations in Antiretroviral Therapy Use in Adolescents with HIV Adherence to Antiretroviral Therapy in Children and Adolescents Living with HIV
Overview
CNS Toxicity
Dyslipidemia
Gastrointestinal Effects
Hematologic Effects
Hepatic Events
Insulin Resistance, Asymptomatic Hyperglycemia, Diabetes Mellitus
Lactic Acidosis
Lipodystrophies and Weight Gain
Nephrotoxic Effects
Osteopenia and Osteoporosis
Rash and Hypersensitivity Reactions
Overview
Modifying Antiretroviral Regimens in Children with Sustained Virologic Suppression on Antiretroviral Therapy
Recognizing and Managing Antiretroviral Treatment Failure
Antiretroviral Treatment Interruption in Children with HIV
Overview
Abacavir
Emtricitabine
Lamivudine
Tenofovir AF
Tenofovir DF
Zidovudine
Doravirine
Efavirenz
Etravirine
Nevirapine
Rilpivirine
Atazanavir
Darunavir
Lopinavir/Ritonavir
Ibalizumab
Maraviroc
Bictegravir
Dolutegravir
Elvitegravir
Raltegravir
Cobicistat
Ritonavir
Appendix A, Table 1. Antiretrovirals Available in Fixed-Dose Combination Tablets
Appendix A, Table 2. Antiretroviral Fixed-Dose Combination Tablets: Minimum Body Weights and Considerations for Use in Children and Adolescents
Overview
Didanosine
Enfuvirtide
Fosamprenavir
Indinavir
Nelfinavir
Saquinavir
Stavudine
Tipranavir
Drug Abbreviations
General Terms
Appendix C: Supplemental Information

Download Guidelines

  • Full GuidelinePDF (3.47 MB)
  • Recommendations OnlyPDF (244.84 KB)
  • Tables OnlyPDF (422.62 KB)
  • Drug Tables OnlyPDF (381.26 KB)

Related Content

  • Clinical Info Drug Database
  • Clinical Info Patient Materials: HIV and Children and Adolescents
  • Clinical Info Infographics
  • AETC National HIV Curriculum
  • How to Cite These Guidelines
  • Guidelines Archive

Appendix A: Pediatric Antiretroviral Drug Information

Overview

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)

Abacavir
Emtricitabine
Lamivudine
Tenofovir alafenamide
Tenofovir disoproxil fumarate
Zidovudine

Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)

Doravirine
Efavirenz
Etravirine
Nevirapine
Rilpivirine

Protease Inhibitors (PIs)

Atazanavir
Darunavir
Lopinavir/Ritonavir

Entry and Fusion Inhibitors

Ibalizumab
Maraviroc

Integrase Inhibitors (INSTIs)

Bictegravir
Dolutegravir
Elvitegravir
Raltegravir

Pharmacokinetic Enhancers

Cobicistat
Ritonavir

Fixed-Dose Combinations

Antiretrovirals Available in Fixed-Dose Combination Tablets
Antiretroviral Fixed-Dose Combination Tablets: Minimum Body Weights and Considerations for Use in Children and Adolescents

Archived Drugs

Didanosine
Enfuvirtide
Fosamprenavir
Indinavir
Nelfinavir
Saquinavir
Stavudine
Tipranavir

Download Guidelines

  • Full GuidelinePDF (3.47 MB)
  • Recommendations OnlyPDF (244.84 KB)
  • Tables OnlyPDF (422.62 KB)
  • Drug Tables OnlyPDF (381.26 KB)

Related Content

  • Clinical Info Drug Database
  • Clinical Info Patient Materials: HIV and Children and Adolescents
  • Clinical Info Infographics
  • AETC National HIV Curriculum
  • How to Cite These Guidelines
  • Guidelines Archive

Connect with us

Facebook
Twitter
Instagram
Subscribe

Mobile Apps

Guidelines
Drug Database
Glossary

Footer menu

  • Home
  • About
  • News
  • Contact Us
  • Privacy Policy
  • Sponsors
  • Nondiscrimination Notice
  • Disclaimers
  • Accessibility

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.